BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 25701044)

  • 41. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.
    Servin AL
    FEMS Microbiol Rev; 2004 Oct; 28(4):405-40. PubMed ID: 15374659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis.
    Bercik P; Collins SM
    Adv Exp Med Biol; 2014; 817():279-89. PubMed ID: 24997039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial microbiome of Coptotermes curvignathus (Isoptera: Rhinotermitidae) reflects the coevolution of species and dietary pattern.
    King JH; Mahadi NM; Bong CF; Ong KH; Hassan O
    Insect Sci; 2014 Oct; 21(5):584-96. PubMed ID: 24123989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine disruptors and gut microbiome interactions.
    Hampl R; Stárka L
    Physiol Res; 2020 Sep; 69(Suppl 2):S211-S223. PubMed ID: 33094620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut-brain axis: how the microbiome influences anxiety and depression.
    Foster JA; McVey Neufeld KA
    Trends Neurosci; 2013 May; 36(5):305-12. PubMed ID: 23384445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human gut microbiota and bifidobacteria: from composition to functionality.
    Turroni F; Ribbera A; Foroni E; van Sinderen D; Ventura M
    Antonie Van Leeuwenhoek; 2008 Jun; 94(1):35-50. PubMed ID: 18338233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New aspects of IgA synthesis in the gut.
    Suzuki K; Nakajima A
    Int Immunol; 2014 Sep; 26(9):489-94. PubMed ID: 24872116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obesity and the human microbiome.
    Ley RE
    Curr Opin Gastroenterol; 2010 Jan; 26(1):5-11. PubMed ID: 19901833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin microbiota-host interactions.
    Chen YE; Fischbach MA; Belkaid Y
    Nature; 2018 Jan; 553(7689):427-436. PubMed ID: 29364286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of the microbiota on the host immune system.
    Karczewski J; Poniedziałek B; Adamski Z; Rzymski P
    Autoimmunity; 2014 Dec; 47(8):494-504. PubMed ID: 25019177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota and kin recognition.
    Lizé A; McKay R; Lewis Z
    Trends Ecol Evol; 2013 Jun; 28(6):325-6. PubMed ID: 23141109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogens, Commensal Symbionts, and Pathobionts: Discovery and Functional Effects on the Host.
    Hornef M
    ILAR J; 2015; 56(2):159-62. PubMed ID: 26323625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inter-kingdom signaling between gut microbiota and their host.
    Li Q; Ren Y; Fu X
    Cell Mol Life Sci; 2019 Jun; 76(12):2383-2389. PubMed ID: 30911771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mosquito microbiota and its influence on disease vectorial transmission].
    Heu K; Gendrin M
    Biol Aujourdhui; 2018; 212(3-4):119-136. PubMed ID: 30973141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ex vivo systems to study host-microbiota interactions in the gastrointestinal tract.
    Roeselers G; Ponomarenko M; Lukovac S; Wortelboer HM
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):101-13. PubMed ID: 23768556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.
    Li H; Jia W
    Clin Pharmacol Ther; 2013 Nov; 94(5):574-81. PubMed ID: 23933971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropeptides and the microbiota-gut-brain axis.
    Holzer P; Farzi A
    Adv Exp Med Biol; 2014; 817():195-219. PubMed ID: 24997035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework.
    Heinken A; Thiele I
    Gut Microbes; 2015; 6(2):120-30. PubMed ID: 25901891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.